Kaimax 200U — Botulinum Toxin Type A (200 Units/Vial)
- 200 units of botulinum toxin type A per vial — vacuum-dried powder (patented vacuum-drying technology)
- 99.8% purity; low protein content minimizes immunogenicity risk for repeat treatments
- Original European strain, legally in-licensed — strain gene sequence registered in NCBI (CP046450)
- Clinically validated: multicenter, randomized, double-blind, placebo-controlled Phase 2 study in moderate-to-severe glabellar lines (480 subjects)
- Standard dilution: 5 mL preservative-free 0.9% saline per 200 U → 4 U / 0.1 mL
- Use within 24 hours after reconstitution at 2–8°C; cold-chain required
- Origin: South Korea; regulated professional product for licensed healthcare professionals only
| 1 – 2 boxes | $45.20 / box |
| 3 – 9 boxes | $42.94 / box |
| 10 – 19 boxes | $40.68 / box |
| 20 – 29 boxes | $39.32 / box |
| 30+ boxes | Contact for quote |
What Is Kaimax 200U — Botulinum Toxin Type A (200 Units/Vial)?
A high-purity botulinum toxin type A complex (200 units per vial) supplied as a vacuum-dried powder for professional injection. It temporarily relaxes targeted muscles by blocking acetylcholine release at the neuromuscular junction, improving moderate-to-severe glabellar lines and supporting larger multi-zone facial and therapeutic treatment protocols.
Kaimax 200U is a high-purity botulinum toxin type A complex supplied as a vacuum-dried powder in a transparent glass vial. Developed from an original European strain legally in-licensed by the manufacturer — the first such strain introduced in Korea — with its gene sequence registered in the NCBI database. Following injection, the toxin binds to motor nerve terminals and cleaves SNAP-25, blocking acetylcholine release so the treated muscle relaxes and dynamic wrinkles become visibly shallower. The formulation achieves 99.8% purity with a low protein content that minimizes immunogenicity risk. Clinically validated in a multicenter, randomized, double-blind, placebo-controlled Phase 2 study (JTM201) in patients with moderate-to-severe glabellar lines. The 200-unit presentation suits practitioners managing larger treatment volumes — multi-zone facial sessions, bilateral masseter contouring and full-face protocols. Cold-chain shipping (2–8°C) is required from manufacturer to clinic. Supplied to licensed healthcare professionals only.
Specifications
| Product name | Kaimax 200U |
|---|---|
| Product type | Botulinum toxin type A neurotoxin complex — vacuum-dried powder for injection |
| Active ingredient | Clostridium botulinum toxin type A, 200 units per vial |
| Presentation | 1 vial × 200 units per box (vacuum-dried powder) |
| Purity | 99.8% |
| Excipients | Human serum albumin 1.0 mg, sodium chloride 1.8 mg |
| Mechanism of action | Cleaves SNAP-25, blocking acetylcholine release at the neuromuscular junction and temporarily relaxing treated muscles |
| Indication | Temporary improvement of moderate-to-severe glabellar lines and other dynamic wrinkles in adult patients |
| Treatment areas | Glabellar lines, forehead lines, crow's feet, masseter contouring, platysma bands |
| Onset of action | 3–7 days (typical clinical range) |
| Duration of effect | 3–6 months (dose- and area-dependent; median 3.2 months in multi-center trials) |
| Reconstitution | Preservative-free 0.9% sodium chloride (5 mL per 200 U → 4 U / 0.1 mL) |
| Storage | 2–8°C, protected from light; do not freeze (cold-chain required) |
| Shelf life | 36 months (unopened) |
| Use after reconstitution | Within 24 hours at 2–8°C |
| Origin | South Korea |
Key Benefits
- Economical 200-unit vial — ideal for multi-zone facial treatments, larger muscle groups and higher-dose protocols
- 99.8% high-purity formulation supports consistent results and a low risk of protein aggregation
- Low protein content reduces immunogenicity risk, supporting repeated treatment sessions
- Backed by a multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical study
- Versatile: glabellar lines, forehead lines, crow's feet, masseter contouring and more
- Reliable, predictable muscle relaxation for natural-looking results that preserve facial expression
Suggested Treatment Protocol
For professional use only. Reconstitute with preservative-free 0.9% sodium chloride (standard: 5 mL per 200 U vial, yielding 4 U per 0.1 mL). Inject the saline slowly down the inner vial wall — do not shake — and gently swirl until the powder is fully dissolved. The solution should be clear and free of particles; use within 24 hours when stored at 2–8°C. Glabellar lines: 20 U total — 0.1 mL (4 U) at each of five points (two per corrugator muscle and one in the procerus muscle), using a 30-gauge needle. Forehead lines: 10–16 U across 4–6 injection points. Crow's feet: approximately 12 U per side across 3 injection points. Masseter contouring and therapeutic dosing follow individual clinical protocols. Avoid diffusion into the levator palpebrae superioris and zygomaticus major. Contraindicated in patients with hypersensitivity to any component, neuromuscular disorders, and during pregnancy or lactation. Avoid concomitant use of aminoglycosides or agents interfering with neuromuscular transmission.
Frequently Asked Questions
What is Kaimax 200U?
Kaimax 200U is a high-purity botulinum toxin type A complex (200 units per vial) supplied as a vacuum-dried powder. It temporarily relaxes treated muscles by blocking acetylcholine release, making dynamic wrinkles such as glabellar lines visibly shallower.
What strain is Kaimax based on?
Kaimax is produced from an original European strain that was legally in-licensed by the manufacturer — the first such strain introduced in Korea. The strain's gene sequence is registered in the NCBI database (accession CP046450), providing full traceability.
How is Kaimax 200U reconstituted?
Reconstitute with preservative-free 0.9% sodium chloride — the standard dilution for a 200 U vial is 5 mL, yielding 4 U per 0.1 mL. Inject the saline slowly down the inner vial wall, do not shake, and gently swirl until fully dissolved. Use within 24 hours when stored at 2–8°C.
When do results appear and how long do they last?
Onset of action typically occurs within 3–7 days, with the full effect visible around 10–14 days. Results usually last 3–6 months depending on the treated area, dosage and individual metabolism (median 3.2 months in multi-center trials).
What is the 200-unit presentation used for?
The 200-unit vial suits practitioners managing larger treatment volumes: multi-zone facial sessions, bilateral masseter contouring, full-face protocols and higher cumulative doses, while still covering standard glabellar (20 U), forehead (10–16 U) and crow's feet (12 U per side) protocols.
Do you offer wholesale pricing?
Yes. Volume discounts apply: 3–9 boxes 5% off, 10–19 boxes 10% off, 20–29 boxes 13% off, and 30+ boxes contact us for a quote.
Kaimax 200U is my go-to for multi-zone sessions — the 5 mL reconstitution to 4 U / 0.1 mL keeps dosing consistent across glabellar, forehead and masseter work. Patients respond within the expected window and the low-protein formulation gives confidence for repeat treatments.
The 200-unit vial offers great value for full-face protocols. The vacuum-dried powder dissolved cleanly with 5 mL saline, results lasted over three months, and the cold-chain packaging arrived perfectly intact. Highly recommended alongside the 100-unit size.
Please log in to leave a review.